Application note: Multiplexed automated imaging assay for cardiotoxic compounds using the ImageXpress Pico system 5SHARES Share via Pinterest Reddit Buffer Xing WhatsApp Flipboard Posted: 13 September 2019 | Molecular Devices | No comments yet There is an increasing need to expand the variety and complexity of cell-based assays for biologic research and drug discovery. Stem cell-derived cells and tissues have become an increasingly attractive alternative to traditional in vitro and in vivo testing in pharmaceutical drug development and toxicological safety assessment. In this study, Molecular Devices scientists used human induced pluripotent stem cell (iPSC)-derived cardiomyocytes to develop functional and morphological readouts for testing effects of different compounds in a multi-parametric assay format, using the ImageXpress Pico Automated Cell Imaging System. To read this application note in full, please complete the form below. By clicking submit you confirm that you accept our terms and conditions and privacy policy. First Name * Surname * Job Title * Organisation * Town/City * Country * Email * Telephone * * This content is provided to you for free thanks to the kind support of our sponsors: Molecular Devices I am happy for my details to be shared with the sponsor(s) of this content *—Please choose an option—YesNo Related content from this organisation Advanced techniques in toxicity testing Women in Stem with Vicky Marsh Durban Patient-derived organoids in disease modelling The role of CRISPR in microbiome engineering breakthroughs Episode 15 – Minimise variability issues in your organoids Related topicsAssays, Stem Cells Related organisationsMolecular Devices
article Advancements in hit identification for membrane protein drug discovery By Philip Rawlins (Group Leader at Domainex)
webinar Advancing ADC Development: End-to-End Solutions from Design to Characterization By Eurofins Discovery